Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Jennifer Quan"'
Publikováno v:
Revista Română de Informatică și Automatică, Vol 31, Iss 1, Pp 89-100 (2021)
Alongside with the progressive globalization and increased competition, the labour market is exposed to high employee turnover. Particularly, organizations face the loss of highly skilled employees as well as high turnover costs. In the coming decade
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1061bb940ad40a008931d91b1e145adc
https://rria.ici.ro/wp-content/uploads/2021/03/art._Hauer_Quan_Liang.pdf
https://rria.ici.ro/wp-content/uploads/2021/03/art._Hauer_Quan_Liang.pdf
Autor:
Sebastian Klein, Nora Wuerdemann, Imke Demers, Christopher Kopp, Jennifer Quantius, Arthur Charpentier, Yuri Tolkach, Klaus Brinker, Shachi Jenny Sharma, Julie George, Jochen Hess, Fabian Stögbauer, Martin Lacko, Marijn Struijlaart, Mari F.C.M. van den Hout, Steffen Wagner, Claus Wittekindt, Christine Langer, Christoph Arens, Reinhard Buettner, Alexander Quaas, Hans Christian Reinhardt, Ernst-Jan Speel, Jens Peter Klussmann
Publikováno v:
npj Digital Medicine, Vol 6, Iss 1, Pp 1-11 (2023)
Abstract Human Papilloma Virus (HPV)-associated oropharyngeal squamous cell cancer (OPSCC) represents an OPSCC subgroup with an overall good prognosis with a rising incidence in Western countries. Multiple lines of evidence suggest that HPV-associate
Externí odkaz:
https://doaj.org/article/f7d0384c46ef4d72a45339eb8dbc1743
Publikováno v:
Romanian Journal of Information Technology & Automatic Control / Revista Română de Informatică și Automatică; 2021, Vol. 31 Issue 1, p89-100, 12p
Autor:
Jaafar A. El-Awady, Jennifer Quan, Shahram Sharafat, Nasr M. Ghoniem, Hyoungil Kim, Vijay Gupta
Publikováno v:
Scopus-Elsevier
The High Average Power Laser (HAPL) project is pursuing development of an IFE power reactor using a solid first wall chamber. Tungsten has been chosen as the primary candidate armor material protecting the low activation ferritic steel chamber wall s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35aa522cb9f48f60d467015193a743ef
https://doi.org/10.13182/fst07-a1603
https://doi.org/10.13182/fst07-a1603
Autor:
He-Jing Wang, Albert Lai, Robert Elashoff, Phioanh L. Nghiemphu, Benjamin M. Ellingson, Reshmi Chowdhury, William H. Yong, Whitney B. Pope, Jennifer Quan, Sichen Li, Richard M. Green, Desiree Sanchez, Shadi Lalezari, Mira Zurayk, James Wawrzynski, Julia Selfridge, Linda M. Liau, Timothy F. Cloughesy, Arthur P. Chou, David Piccioni, Reema R. Mody
Publikováno v:
NEURO-ONCOLOGY, vol 16, iss 6
Piccioni, DE; Selfridge, J; Mody, RR; Chowdhury, R; Li, S; Lalezari, S; et al.(2014). Deferred use of bevacizumab for recurrent glioblastoma is not associated with diminished efficacy. Neuro-Oncology, 16(6), 815-822. doi: 10.1093/neuonc/nou028. UCLA: Retrieved from: http://www.escholarship.org/uc/item/4t10v8ch
Neuro-oncology, vol 16, iss 6
Piccioni, DE; Selfridge, J; Mody, RR; Chowdhury, R; Li, S; Lalezari, S; et al.(2014). Deferred use of bevacizumab for recurrent glioblastoma is not associated with diminished efficacy. NEURO-ONCOLOGY, 16(6), 815-822. doi: 10.1093/neuonc/nou028. UCLA: Retrieved from: http://www.escholarship.org/uc/item/53j8v4ft
Piccioni, DE; Selfridge, J; Mody, RR; Chowdhury, R; Li, S; Lalezari, S; et al.(2014). Deferred use of bevacizumab for recurrent glioblastoma is not associated with diminished efficacy. Neuro-Oncology, 16(6), 815-822. doi: 10.1093/neuonc/nou028. UCLA: Retrieved from: http://www.escholarship.org/uc/item/4t10v8ch
Neuro-oncology, vol 16, iss 6
Piccioni, DE; Selfridge, J; Mody, RR; Chowdhury, R; Li, S; Lalezari, S; et al.(2014). Deferred use of bevacizumab for recurrent glioblastoma is not associated with diminished efficacy. NEURO-ONCOLOGY, 16(6), 815-822. doi: 10.1093/neuonc/nou028. UCLA: Retrieved from: http://www.escholarship.org/uc/item/53j8v4ft
We would like to thank D’Alessandris and colleagues for their interest in our study. We agree that following 2 negative phase III trials of upfront bevacizumab, both with significant crossover in the placebo arms, the optimal timing of bevacizumab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84e7a860ced82a19e7818584472409f2
https://escholarship.org/uc/item/53j8v4ft
https://escholarship.org/uc/item/53j8v4ft
Publikováno v:
Neurology. 78:P04.183-P04.183
Objective: We hypothesized that bevacizumab (bev) with or without temozolomide (TMZ) might be effective in treating unresectable pilocytic astrocytoma (PA) in adults. Background PA is a WHO Grade I tumor that is often not completely resectable. TMZ,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d5f2c523420877364a4861ab699ef5b5
https://doi.org/10.1212/wnl.78.1_meetingabstracts.p04.183
https://doi.org/10.1212/wnl.78.1_meetingabstracts.p04.183
Autor:
Jordi Ruiz‐Camp, Jennifer Quantius, Ettore Lignelli, Philipp F Arndt, Francesco Palumbo, Claudio Nardiello, David E Surate Solaligue, Elpidoforos Sakkas, Ivana Mižíková, José Alberto Rodríguez‐Castillo, István Vadász, William D Richardson, Katrin Ahlbrecht, Susanne Herold, Werner Seeger, Rory E Morty
Publikováno v:
EMBO Molecular Medicine, Vol 11, Iss 3, Pp 1-17 (2019)
Abstract Bronchopulmonary dysplasia (BPD) is a common complication of preterm birth characterized by arrested lung alveolarization, which generates lungs that are incompetent for effective gas exchange. We report here deregulated expression of miR‐
Externí odkaz:
https://doaj.org/article/a42a55dd9bab46738adc210265227750
Autor:
Jennifer Quantius, Carole Schmoldt, Ana I Vazquez-Armendariz, Christin Becker, Elie El Agha, Jochen Wilhelm, Rory E Morty, István Vadász, Konstantin Mayer, Stefan Gattenloehner, Ludger Fink, Mikhail Matrosovich, Xiaokun Li, Werner Seeger, Juergen Lohmeyer, Saverio Bellusci, Susanne Herold
Publikováno v:
PLoS Pathogens, Vol 12, Iss 6, p e1005544 (2016)
Influenza Virus (IV) pneumonia is associated with severe damage of the lung epithelium and respiratory failure. Apart from efficient host defense, structural repair of the injured epithelium is crucial for survival of severe pneumonia. The molecular
Externí odkaz:
https://doaj.org/article/2bfa5c69e1f5438eb45ed4d593fc7dab